Order Article Reprints

Ceruti T, D’Alessandris QG, Frapolli R, Gopalakrishnan J, Buccarelli M, Meroni M, Lauretti L, Ricci-Vitiani L, Pallini R, Zucchetti M. Development and Validation of a HPLC–MS/MS Method to Measure Nifuroxazide and Its Application in Healthy and Glioblastoma-Bearing Mice. Pharmaceutics. 2022; 14(10):2071. https://doi.org/10.3390/pharmaceutics14102071

Ceruti, Tommaso, Quintino Giorgio D’Alessandris, Roberta Frapolli, Jay Gopalakrishnan, Mariachiara Buccarelli, Marina Meroni, Liverana Lauretti, Lucia Ricci-Vitiani, Roberto Pallini, and Massimo Zucchetti. 2022. "Development and Validation of a HPLC–MS/MS Method to Measure Nifuroxazide and Its Application in Healthy and Glioblastoma-Bearing Mice" Pharmaceutics 14, no. 10: 2071. https://doi.org/10.3390/pharmaceutics14102071

Ceruti, T., D’Alessandris, Q. G., Frapolli, R., Gopalakrishnan, J., Buccarelli, M., Meroni, M., Lauretti, L., Ricci-Vitiani, L., Pallini, R., & Zucchetti, M. (2022). Development and Validation of a HPLC–MS/MS Method to Measure Nifuroxazide and Its Application in Healthy and Glioblastoma-Bearing Mice. Pharmaceutics, 14(10), 2071. https://doi.org/10.3390/pharmaceutics14102071